Analysis of diagnosis and treatment of IgG4-related disease involving the nasal cavity and skull base（with 8 case reports）.
10.13201/j.issn.2096-7993.2025.06.010
- Author:
Wei ZHONG
1
;
Xuan YUAN
1
;
Lai MENG
1
;
Jiaxin JIA
1
;
Shaobing XIE
1
;
Shumin XIE
1
;
Junyi ZHANG
1
;
Hua ZHANG
1
;
Weihong JIANG
1
;
Zhihai XIE
1
Author Information
1. Department of Otolaryngology Head and Neck Surgery，Xiangya Hospital of Central South University，Hu'nan Province Key Laboratory of Otolaryngology Critical Diseases，Changsha，410008，China.
- Publication Type:English Abstract
- Keywords:
IgG4-related disease;
diagnosis;
paranasal sinus;
skull base;
treatment
- MeSH:
Humans;
Male;
Skull Base/pathology*;
Female;
Middle Aged;
Retrospective Studies;
Aged;
Nasal Cavity/pathology*;
Adult;
Immunoglobulin G4-Related Disease/therapy*;
Immunoglobulin G;
Child;
Young Adult;
Adolescent
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2025;39(6):553-558
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinical diagnosis and treatment of IgG4-related disease（IgG4-RD） primarily involving the nasal cavity and skull base. Methods:A retrospective analysis was conducted on the clinical data of 8 patients with IgG4-RD primarily involving the nasal cavity and skull base who visited the Nasal and Skull Base Surgery Department at Xiangya Hospital from October 2017 to January 2024. The cohort comprised 4 males and 4 females, aged 8 to 69 years. Clinical data, laboratory examination results, imaging findings, histopathological results, and treatment plans were collected. The clinical manifestations, diagnosis, treatment and follow-up results of IgG4-RD primarily involving nasal cavity and skull base were summarized and previous literature were also reviewed. Results:The initial symptoms in the 8 patients included nasal congestion, headache, sensory function decline, and facial deformities. Three patients also had parotid and pulmonary involvement. Among the 8 patients, 4 underwent partial surgical resection combined with glucocorticoid therapy; 1 underwent partial surgical resection combined with glucocorticoid and immunosuppressant therapy; 1 received glucocorticoid therapy alone; and 2 received glucocorticoid combined with immunosuppressant therapy. Follow-up was conducted one month after treatment, lasting from 5 to 79 months. During the follow-up period, recurrence was observed in 1 patient treated with glucocorticoid combined with immunosuppressants and in 1 patient treated with glucocorticoid alone, while the other 6 patients achieved significant remission. Conclusion:The diagnosis of nasal cavity and skull base IgG4-RD requires the combination of histopathology, laboratory tests, and imaging results. Treatment primarily includes glucocorticoids or combined immunosuppressants. For patients with significant compression symptoms, sensory function impairment, or facial deformities, surgical resection is an important treatment option. Given the high risk of recurrence, early intervention, active treatment, and long-term follow-up are crucial.
